Home > Insider Trading > Filing (0000899243-16-029007)

Filing Details

Accession Number:: 0000899243-16-029007
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-09-14 21:04:50
Reporting Period:: 2016-09-12

Filing Date:: 2016-09-14
Accepted Time:: 2016-09-14 21:04:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1520697	Acadia Healthcare Company Inc.	ACHC	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1299241	Waud Capital Partners Ii, L.p.	300 N. Lasalle Street, Suite 4900 Chicago IL 60654	No	No	Yes	No
1299294	Waud Capital Partners Qp Ii, L.p.	300 N. Lasalle Street, Suite 4900 Chicago IL 60654	No	No	Yes	No
1532445	Waud Capital Partners Ii, L.l.c.	300 N. Lasalle Street, Suite 4900 Chicago IL 60654	No	No	Yes	No
1532459	Waud Capital Partners Management Ii, L.p.	300 N. Lasalle Street, Suite 4900 Chicago IL 60654	No	No	Yes	No
1532463	Wcp Fif Ii (Acadia), L.p.	300 N. Lasalle Street, Suite 4900 Chicago IL 60654	No	No	Yes	No
1532464	Waud Capital Affiliates Ii, L.l.c.	300 N. Lasalle Street, Suite 4900 Chicago IL 60654	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.01 Per Share	Disposition	2016-09-12	48,321	$51.77	4,707,214	No	4	S	Indirect	See footnotes
Common Stock, Par Value $0.01 Per Share	Disposition	2016-09-13	5,933	$51.23	4,701,281	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Footnotes

Represents shares sold in multiple transactions under Rule 144 as follows: (i) 9,095 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 27,464 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 5,811 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 5,951 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II").
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.58 to $52.01, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4.
Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares.
Represents shares sold in multiple transactions under Rule 144 as follows: (i) 1,117 shares by WCP II, (ii) 3,372 shares by Waud QP II, (iii) 713 shares by WCP FIF II and (iv) 731 shares by Waud Affiliates II.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.15 to $51.85, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4.
The reported shares are owned of record as follows: (i) 1,297,373 shares by WCP II, (ii) 2,557,606 shares by Waud QP II, (iii) 418,098 shares by WCP FIF II and (iv) 428,204 shares by Waud Affiliates II.
Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein.